PMGC Holdings (ELAB) EPS (Basic) (2022 - 2026)
PMGC Holdings' (ELAB) quarterly EPS (Basic) came in at -$8.84 in Q2 2026, down 176.37% year-over-year from $11.57 in Q2 2025, and up 89.46% quarter-over-quarter from -$83.8 in Q1 2026.
Powered by 
Analysis
PMGC Holdings (ELAB) EPS (Basic) (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed EPS (Basic) across 5 years of filings, most recently posting -$8.84 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 176.37% year-over-year to -$8.84; the TTM figure through Jun 2026 stood at -$26.47 (up 98.13% YoY), while the FY2025 annual figure was $4121.3, up 117.56% from the prior year.
- EPS (Basic) came in at -$8.84 for Q2 2026 at PMGC Holdings, up from -$83.8 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $11.57 in Q2 2025 to a low of -$1.7 million in Q4 2023.
- Average EPS (Basic) over 5 years is -$170131.1, with a median of -$598.94 recorded in 2024.
- Year-over-year, EPS (Basic) surged 101.57% in 2025 and plunged 176.37% in 2026.
- Over 5 years, EPS (Basic) stood at -$706854.2 in 2022, then plunged by 142.96% to -$1.7 million in 2023, then surged by 99.87% to -$2283.3 in 2024, then surged by 45.34% to -$1248.1 in 2025, then soared by 99.29% to -$8.84 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$8.84 in Q2 2026, -$83.8 in Q1 2026, and -$1248.1 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.40 Bn | 192.42 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.11 Bn | 123.26 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.67 Bn | 73.68 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.56 Bn | 55.37 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.69 Bn | 48.56 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.40 Bn | 30.09 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.78 Bn | 30.49 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.09 Bn | 29.09 Bn | 1.16 Mn | -0.40 |
| 10 | PMGC Holdings | 2.31 Mn | -16.49 Mn | 385,691.00 | -8.84 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.84 |
| Mar 31, 2026 | -83.80 |
| Dec 31, 2025 | -1,248.06 |
| Sep 30, 2025 | -1,059.16 |
| Jun 30, 2025 | 11.57 |
| Mar 31, 2025 | -42.66 |
| Dec 31, 2024 | -2,283.26 |
| Sep 30, 2024 | -574.79 |
| Jun 30, 2024 | -738.73 |
| Mar 31, 2024 | -571.22 |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | -464.07 |
| Jun 30, 2023 | -623.09 |
| Mar 31, 2023 | -509.56 |
| Dec 31, 2022 | -706,854.25 |
| Sep 30, 2022 | -289,706.17 |